関連する実験動画
Updated: Feb 14, 2026
11:27
Synthesis and Characterization of Functionalized Metal-organic Frameworks
Published on: September 5, 2014
49.3K
癌治療のための金属有機フレームワークベースの薬物投与システム:レビュー
Sedigheh Hatami1, Khaled Chahrour2,3, Joelle El Fakhouri4
1Biomedical Engineering Program, College of Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
International journal of molecular sciences
|February 13, 2026
まとめ
メタル・オーガニック・フレームワーク (MOF) は,新しい薬剤投与システムを介して,先進的ながん治療を提供しています. このレビューは,研究者がMOFを有効で標的を絞ったがん治療と制御された薬剤の放出のために利用することをガイドしています.
科学分野:
- 材料科学 材料科学とは
- ナノテクノロジー ナノテクノロジー ナノテクノロジー
- バイオメディカルエンジニアリング
背景:
- がんは世界的な健康問題であり,従来の治療法には副作用や薬剤耐性などの限界があります.
- メタル・オーガニック・フレームワーク (MOF) は,高表面積,調節可能な構造,生物分解性などのユニークな特性を有しており,がん治療に有望です.
研究 の 目的:
- バイオメディカルアプリケーションにおけるがん治療のためのMOFベースの薬物投与システムをレビューする.
- MOFを有効ながん治療法に変換する研究者のための実践的なガイドを提供する.
- 癌治療の進歩における刺激反応性MOFの役割を強調する.
主な方法:
- 薬物投与に関連する様々なMOF合成方法についての議論.
- MOFに異なる薬物ロード戦略の分析.
- MOFベースのシステムの細胞毒性および生物互換性の検討.
主要な成果:
- MOFは,そのユニークな物理化学的特性により,薬剤の投与を向上させる可能性を示しています.
- 刺激に反応するMOFは,標的がん治療と薬物の放出を制御する有望な効果を示しています.
- 最近の研究は,前臨床がんモデルにおけるMOFベースのシステムの有効性を実証しています.
結論:
- MOFは,次世代がん治療法の開発のための汎用性のあるプラットフォームを表しています.
- 化学 - 構造 - 性質 - 応用関係の理解は,腫瘍学におけるMOFの開発に不可欠です.
- MOFベースの薬物投与システムは,がん治療の成果を改善するための重要な機会を提供します.
さらに関連する動画
関連する概念動画
01:18Transdermal Drug Delivery Systems
4
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
4
01:23Ophthalmic Drug Delivery Systems
4
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
4
01:21Intrauterine Drug Delivery Systems
3
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
3
01:27Drug Delivery Systems: Different Types
2
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
2
01:26Oral Drug Delivery Systems: Continuous-Release Systems
2
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
2
01:11Oral Drug Delivery Systems: Delayed-Release Systems
3
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
3